IP Library Granted Patent US 10,688,117
Granted Patent B2
US 10,688,117 · App. 15/955,371 · Granted Jun 23, 2020

Topical wash composition for use in acne patients

Inventor: Karine Nadau Fourcade (Villeneuve Loubet, FR)
Assignee: GALDERMA S.A.
A61K31/704A61K8/27A61K8/365A61K8/463A61K8/466A61K8/63A61K31/19A61K31/191A61K31/315A61K31/56A61K33/30A61Q19/10A61K2800/58
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,688,117
App. No.
15/955,371
Granted
Jun 23, 2020
Kind
B2
Abstract

Wash compositions for topical application are described. The compositions can be stable and well tolerated. Also described, are methods of using such compositions as cosmetic or pharmaceutical products. For example, the compositions can be used for cleansing the skin, preferably of acne patients, without compromising the skin barrier or resulting in over-compensation of sebum production. A topical wash composition is also described that can include: a) at least one surfactant; b) a zinc salt of gluconic acid; and c) a salt or derivative of glycyrrhizic acid or of glycyrrhetinic acid.

Claims (49)

1. A foaming topical wash composition consisting of:

(a) between 1% and 10% by weight of zinc coceth sulfate of active material (AM) relative to the total weight of the composition;

(b) between 0.15% and 0.3% by weight of zinc gluconate relative to the total weight of the composition; and

(c) between 0.25% and 0.3% by weight of dipotassium glycyrrhizate relative to the total weight of the composition; and

(d) one or more pharmaceutically acceptable excipients selected from the group consisting of: (i) gelling agents; (ii) viscosity increasing agents; (iii) emulsifiers; (iv) antioxidants selected from the group consisting of vitamin E and its derivatives, vitamin C and its derivatives, butylated hydroxytoluene, butylated hydroxyanisole, acetyl cysteine, citric acid, sodium metabisulfite, sodium sulfite, and combinations thereof; (v) vitamins and/or vitamin derivatives selected from the group consisting of vitamin E and its derivatives, vitamin C and its derivatives, vitamin B3, niacinamide, and combinations thereof; (vi) soothing agents and/or anti-irritants selected from the group consisting of PPG-12/SMDI copolymer, allantoin and its derivatives, hyaluronic acid, polyquaternium-51, D-panthenol, and aloe vera; (vii) lecithins and/or phospholipids; (viii) cholesterol and/or cholesterol derivatives; (ix) preservatives; (x) acids and/or bases; (xi) chelating agents; (xii) humectants; (xiii) wetting agents; (xiv) foam boosters; (xv) ingredients providing a smoothness of the foam; (xvi) perfume solubilizing agents; (xvii) perfumes and/or fragrances; (xviii) refatting agents; (xix) mineral, synthetic, or silicone oils; and (xx) water,

wherein the foaming topical wash composition does not contain ethanol.

2. The topical wash composition according to claim 1 , wherein the concentration of zinc gluconate is 0.20%.

3. The topical wash composition according to claim 1 , wherein the concentration of dipotassium glycyrrhizate is 0.25%.

4. The topical wash composition according to claim 1 , wherein the pH of the topical wash composition is from about 3 to about 6.

5. The topical wash composition according to claim 1 , wherein the pH of the topical wash composition is from about 3.5 to about 5.0.

6. The composition of claim 1 , wherein the gelling agents are selected from the group consisting of microcrystalline cellulose, sodium carboxymethylcellulose, hydroxypropylmethylcellulose, carbomers, polysaccharides, magnesium aluminum silicate, sodium magnesium silicate, sodium magnesium fluorosilicate, magnesium sodium silicate, tetrasodium pyrophosphate, the family of acrylic polymers, acrylate copolymers, polyacrylate-13/polyisobutylene/polysorbate-20, gelling agents of the polyacrylamide family, the family of modified starches, and mixtures thereof.

7. The composition of claim 1 , wherein the viscosity increasing agents are selected from the group consisting of sodium chloride, PEG-120 methyl glucose dioleate, PEG-200 hydrogenated glyceryl palmate, PEG-7 glyceryl cocoate, ceteareth-60 myristyl glycol, and combinations thereof.

8. The composition of claim 1 , wherein the lecithins and/or phospholipids are selected from the group consisting of phosphatidyl choline, phosphatidyl inositol, phosphatidyl ethanolamine, phosphatidic acid, Phospholipon 90H, and mixtures thereof.

9. The composition of claim 1 , wherein the preservatives are selected from the group consisting of benzalkonium chloride, bronopol, chlorhexidine, chlorocresol and its derivatives, phenoxyethanol, potassium sorbate, sodium benzoate, diazolidinylurea, benzyl alcohol, parabens, and mixtures thereof.

10. The composition of claim 1 , wherein the acids and/or bases are selected from the group consisting of citric acid, lactic acid, sodium citrate, triethanolamine, aminomethyl propanol, sodium hydroxide, diisopropanolamine, and mixtures thereof.

11. The composition of claim 1 , wherein the humectants are selected from the group consisting of propylene glycol, glycerin, pentylene glycol, 1-2 hexanediol, caprylyl glycol, and mixtures thereof.

12. The composition of claim 1 , wherein the wetting agents are selected from the group consisting of poloxamers, glycols, sodium docusate, and mixtures thereof.

13. The composition of claim 1 , wherein the ingredients providing a smoothness of the foam are selected from the group consisting of PEG-7 glyceryl cocoate, PEG-200 hydrogenated glyceryl palmate, polypropylene terephthalate, Cl2-13 alkyl lactate, and combinations thereof.

14. The composition of claim 1 , wherein the foam boosters are selected from the group consisting of polyethylene glycols, glycerylmonocaprylate, cocamidopropyl hydroxysultaine, sorbitan sesquicaprylate, and combinations thereof.

15. The composition of claim 1 , wherein the perfume solubilizing agents are selected from PEG-40 hydrogenated castor oil, PEG-60 hydrogenated castor oil, polysorbate 80, polysorbate 20, and mixtures thereof.

16. The composition of claim 1 , wherein the refatting agents are selected from coco-glucoside, glyceryl oleate, and PEG-6-caprylic/capric glycerides, and mixtures thereof.

17. The topical wash composition according to claim 1 , consisting of:

Purified water

QSAD 100

Zinc coceth sulfate (25% in water)

19.50% 

Glycerin

  4%

Dipotassium glycyrrhizate

0.25%

Zinc gluconate

0.20%

PEG-200 hydrogenated glyceryl palmate and

0.30%

PEG-7 glyceryl cocoate

PEG-75

  2%

Sodium benzoate

0.20%

Disodium EDTA

0.10%

PEG-40 hydrogenated castor oil

0.25%, and

Fragrance

 0.25%.

18. A method of cleansing or washing the skin of an acne patient, the method comprising cleansing or washing the skin of the patient in need thereof with the topical wash composition according to claim 1 , wherein the patient is under active treatment or in long-term maintenance.

19. A method of washing acne skin, the method comprising washing the acne skin of a patient in need thereof with the topical wash composition according to claim 1 , wherein a barrier function of the skin is kept intact.

20. A method of regulating sebum production in skin of an acne patient, the method comprising regulating sebum production in the skin of the acne patient in need thereof with the topical wash composition according to claim 1 .

21. A method for improving acne skin, the method comprising administering to the acne skin of an individual subject in need thereof an effective amount of the topical wash composition according to claim 1 .

Assignments (4)
CHANGE OF ADDRESS Recorded Jun 28, 2022
From: GALDERMA HOLDING SA
To: GALDERMA HOLDING SA
Reel/Frame 060541/0374 →
ASSET TRANSFER AGREEMENT Recorded Oct 3, 2021
From: GALDERMA S.A.
To: NESTLÉ SKIN HEALTH S.A.
Reel/Frame 057698/0295 →
CHANGE OF NAME Recorded Oct 3, 2021
From: NESTLÉ SKIN HEALTH S.A.
To: GALDERMA HOLDING SA
Reel/Frame 057698/0356 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2018
From: NADAU FOURCADE, NADINE
To: GALDERMA S.A.
Reel/Frame 045564/0815 →